| 000 | 01469 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517114741.0 | ||
| 264 | 0 | _c20170626 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1471-2334 | ||
| 024 | 7 |
_a10.1186/s12879-016-1825-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan der Geest, Patrick J | |
| 245 | 0 | 0 |
_aMicafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study. _h[electronic resource] |
| 260 |
_bBMC infectious diseases _c09 2016 |
||
| 300 |
_a490 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAPACHE |
| 650 | 0 | 4 | _aAnidulafungin |
| 650 | 0 | 4 |
_aAntifungal Agents _xeconomics |
| 650 | 0 | 4 |
_aCandidiasis, Invasive _xdrug therapy |
| 650 | 0 | 4 | _aCritical Illness |
| 650 | 0 | 4 |
_aEchinocandins _xeconomics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntensive Care Units |
| 650 | 0 | 4 |
_aLipopeptides _xeconomics |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aLiver Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicafungin |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHunfeld, Nicole G M | |
| 700 | 1 | _aLadage, Sophie E | |
| 700 | 1 | _aGroeneveld, A B Johan | |
| 773 | 0 |
_tBMC infectious diseases _gvol. 16 _gp. 490 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12879-016-1825-3 _zAvailable from publisher's website |
| 999 |
_c26423907 _d26423907 |
||